Brand Firm In-House Generics Unlikely To Grab Large Market Share – Analyst
Executive Summary
Brand companies that launch their own generics are unlikely to capture significant market share but will exert pricing pressure on the ANDA first-filer, a Lehman Brothers analyst said
You may also be interested in...
Teva Anticipates “Major Consolidation” In Generic Industry In 2005
Teva is preparing for another round of consolidation within the generic industry during 2005, North America CEO George Barrett said Jan. 13 at the J.P. Morgan health care conference in San Francisco
Teva Anticipates “Major Consolidation” In Generic Industry In 2005
Teva is preparing for another round of consolidation within the generic industry during 2005, North America CEO George Barrett said Jan. 13 at the J.P. Morgan health care conference in San Francisco
Duragesic Competition Could Add To Mylan’s “Authorized” Generics Fight
The anticipated launch of an "authorized" generic of J&J's Duragesic could give Mylan further ammunition in its ongoing fight against such products